Ki67: comment l'évaluer? = How to evaluate Ki67HERLIN, Paulette.Annales de pathologie (Print). 2011, Vol 31, issn 0242-6498, S49-S51, HS1Conference Paper

Ki67: quand l'utiliser? = When to use Ki67SCOAZEC, Jean-Yves.Annales de pathologie (Print). 2011, Vol 31, issn 0242-6498, S52-S54, HS1Conference Paper

Ki67 et tumeurs neuroendocrines = Ki67 and neuroendocrine tumorsCOUVELARD, Anne.Annales de pathologie (Print). 2011, Vol 31, issn 0242-6498, S55-S56, HS1Conference Paper

Ki67, nucléole et cancer = Ki67, nucleolus and cancerMERTANI, Hichem C; BELIN, Stéphane; DIAZ, Jean-Jacques et al.Annales de pathologie (Print). 2011, Vol 31, issn 0242-6498, S46-S48, HS1Conference Paper

Increased Ki-67 proliferative index and absence of P16^INK4in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesionKUO, K.-T; CHANG, H.-C; HSIAO, C.-H et al.British journal of ophthalmology. 2006, Vol 90, Num 7, pp 894-899, issn 0007-1161, 6 p.Article

Nuclear β-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant formWONG, S. C. C; CHAN, A. T. C; CHAN, J. K. C et al.Journal of clinical pathology. 2006, Vol 59, Num 4, pp 387-392, issn 0021-9746, 6 p.Article

An International Ki67 Reproducibility StudyPOLLEY, Mei-Yin C; LEUNG, Samuel C. Y; GOWN, Allen M et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 24, pp 1897-1906, issn 0027-8874, 10 p.Article

Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence scoreSAHEBJAM, S; ALOYZ, R; PILAVDZIC, D et al.British journal of cancer. 2011, Vol 105, Num 9, pp 1342-1345, issn 0007-0920, 4 p.Article

Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumorTSUNEKI, Masayuki; JUN CHENG; MARUYAMA, Satoshi et al.Journal of oral pathology & medicine. 2008, Vol 37, Num 5, pp 287-293, issn 0904-2512, 7 p.Article

Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgeryDUBOIS, S; GUYAETANT, S; MENEI, P et al.European journal of endocrinology. 2007, Vol 157, Num 2, pp 141-147, issn 0804-4643, 7 p.Article

Is Ki67 a marker for the transformation of laryngeal dysplasia to carcinoma?MIRZA, S; JEANNON, J. P; SOAMES, J et al.Acta oto-laryngologica. 2006, Vol 126, Num 4, pp 418-421, issn 0001-6489, 4 p.Article

Up-regulation of peroxidase proliferator- activated receptor_γ in cholesteatomaSOON JAE HWANG; HEE JOON KANG; SONG, Jae-Jun et al.The Laryngoscope. 2006, Vol 116, Num 1, pp 58-61, issn 0023-852X, 4 p.Article

Stromal CD10 expression is correlated with invasiveness and proliferation of extramammary Paget diseaseXIE, L. N; UCHI, H; HAYASHIDA, S et al.British journal of dermatology (1951). 2008, Vol 158, Num 6, pp 1389-1391, issn 0007-0963, 3 p.Article

Histopathological Classification of Pseudomyxoma Peritonei and the Prognostic Importance of PINCH ProteinANDREASSON, Hakan; WANDERS, Alkwin; SUN, Xiao-Feng et al.Anticancer research. 2012, Vol 32, Num 4, pp 1443-1448, issn 0250-7005, 6 p.Article

Comparative validation of the SP6 antibody to Ki67 in breast cancerZABAGLO, Lila; SALTER, Janine; ANDERSON, Helen et al.Journal of clinical pathology. 2010, Vol 63, Num 9, pp 800-804, issn 0021-9746, 5 p.Article

Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphomaBROYDE, Adi; BOYCOV, Olga; STRENOV, Yulia et al.American journal of hematology. 2009, Vol 84, Num 6, pp 338-343, issn 0361-8609, 6 p.Article

The Expression of MT1 Melatonin Receptor and Ki-67 Antigen in Melanoma MalignumDANIELCZYK, Karolina; DZIEGIEL, Piotr.Anticancer research. 2009, Vol 29, Num 10, pp 3887-3895, issn 0250-7005, 9 p.Article

Bcl-2 and Bax in congenital naeviSTEFANAKI, C; ANTONIOU, C; STEFANAKI, K et al.British journal of dermatology (1951). 2006, Vol 154, Num 6, pp 1175-1179, issn 0007-0963, 5 p.Article

Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancyMEHROTRA, Pallavi; GONZALEZ, Michael A; JOHNSON, Sarah J et al.The Laryngoscope. 2006, Vol 116, Num 8, pp 1434-1438, issn 0023-852X, 5 p.Article

Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast CancerVON MINCKWITZ, Gunter; SCHMITT, Wolfgang D; HILFRICH, Jörn et al.Clinical cancer research (Print). 2013, Vol 19, Num 16, pp 4521-4531, issn 1078-0432, 11 p.Article

Critical Role of c-Met and Ki67 in Progress of Biliary CarcinomaSANADA, Yuichi; OSADA, Shinji; TOKUYAMA, Yasuharu et al.The American surgeon. 2010, Vol 76, Num 4, pp 372-379, issn 0003-1348, 8 p.Article

Prognostic Significance of Ki-67 Labeling Index in Papillary Thyroid CarcinomaITO, Yasuhiro; MIYAUCHI, Akira; KAKUDO, Kennichi et al.World journal of surgery. 2010, Vol 34, Num 12, pp 3015-3021, issn 0364-2313, 7 p.Article

Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic LesionsNASR, Michel R; EL-ZAMMAR, Ola.The American journal of dermatopathology. 2008, Vol 30, Num 2, pp 117-122, issn 0193-1091, 6 p.Article

Prognostic Significance of Ki-67 Antigen Expression in Non-Hodgkin's LymphomasSZCZURASZEK, Katarzyna; MAZUR, Grzegorz; JELEN, Michal et al.Anticancer research. 2008, Vol 28, Num 2A, pp 1113-1118, issn 0250-7005, 6 p.Article

Unrepresentative astrocytoma biopsy sampling is partly overcome by assessment of the MIB-1-labelled growth fractionSHEEHAN, Katherine M; KAY, Elaine W; BURKE, Maureen et al.Journal of clinical pathology. 2007, Vol 60, Num 8, pp 945-947, issn 0021-9746, 3 p.Article